ADMA vs. CHOLAFIN.NS

Last updated Jun 13, 2026

ADMA (ADMA Biologics, Inc.) and CHOLAFIN.NS (Cholamandalam Investment and Finance Company Limited) are both stocks. ADMA operates in Biotechnology (Healthcare), while CHOLAFIN.NS operates in Credit Services (Financial Services). Over the past 10 years, ADMA returned 1.84%/yr vs 24.54%/yr for CHOLAFIN.NS. At a 0.04 correlation, their price movements are largely independent.

Performance

ADMA vs. CHOLAFIN.NS - Performance Comparison

The chart below illustrates the hypothetical performance of a $10,000 investment in ADMA Biologics, Inc. (ADMA) and Cholamandalam Investment and Finance Company Limited (CHOLAFIN.NS). The values are adjusted to include any dividend payments, if applicable.

Different Trading Currencies

ADMA is traded in USD, while CHOLAFIN.NS is traded in INR. To make them comparable, the CHOLAFIN.NS values have been converted to USD using the latest available exchange rates.

Returns By Period

In the year-to-date period, ADMA achieves a -54.99% return, which is significantly lower than CHOLAFIN.NS's -12.92% return. Over the past 10 years, ADMA has underperformed CHOLAFIN.NS with an annualized return of 1.84%, while CHOLAFIN.NS has yielded a comparatively higher 24.54% annualized return.

ADMA

• 1D: -1.32%
• 1M: -3.41%
• YTD: -54.99%
• 6M: -58.49%
• 1Y: -61.99%
• 3Y*: 27.09%
• 5Y*: 35.16%
• 10Y*: 1.84%

CHOLAFIN.NS

• 1D: 7.82%
• 1M: 0.16%
• YTD: -12.92%
• 6M: -13.94%
• 1Y: -10.59%
• 3Y*: 7.33%
• 5Y*: 16.75%
• 10Y*: 24.54%

*Multi-year figures are annualized to reflect compound growth (CAGR)

ADMA vs. CHOLAFIN.NS - Yearly Performance Comparison

	2026 (YTD)	2025	2024	2023	2022	2021	2020	2019	2018	2017
ADMA ADMA Biologics, Inc.	-54.99%	6.36%	279.42%	16.49%	175.18%	-27.69%	-51.25%	67.36%	-25.55%	-37.30%
CHOLAFIN.NS Cholamandalam Investment and Finance Company Limited	-12.92%	36.88%	-8.30%	73.77%	25.39%	32.15%	24.43%	31.31%	0.38%	66.96%

Correlation

The correlation between ADMA and CHOLAFIN.NS is -0.07, meaning there is essentially no relationship between their price movements. Each responds to its own set of market drivers, making them strong candidates for combining in a diversified portfolio.

	Correlation
Correlation (1Y) Calculated over the trailing 1-year period	-0.07
Correlation (3Y) Calculated over the trailing 3-year period	0.00
Correlation (5Y) Calculated over the trailing 5-year period	0.04
Correlation (10Y) Calculated over the trailing 10-year period	0.04
Correlation (All Time) Calculated using the full available price history since Oct 17, 2013	0.04

The correlation between ADMA and CHOLAFIN.NS shifts across timeframes, from -0.07 (1 year) to 0.04 (all time), reflecting how their relationship changes across market environments.

Return for Risk

ADMA vs. CHOLAFIN.NS — Risk / Return Rank

Compare risk-adjusted metric ranks to identify better-performing investments over the past 12 months.

ADMA

ADMA Risk / Return Rank: 3
ADMA Sharpe Ratio Rank: 3
ADMA Sortino Ratio Rank: 4
ADMA Omega Ratio Rank: 4
ADMA Calmar Ratio Rank: 3
ADMA Martin Ratio Rank: 1

CHOLAFIN.NS

CHOLAFIN.NS Risk / Return Rank: 40
CHOLAFIN.NS Sharpe Ratio Rank: 42
CHOLAFIN.NS Sortino Ratio Rank: 37
CHOLAFIN.NS Omega Ratio Rank: 36
CHOLAFIN.NS Calmar Ratio Rank: 42
CHOLAFIN.NS Martin Ratio Rank: 41

The rank (0–100) shows how this investment's returns compare to the risk taken. Higher = better. Based on the past 12 months of data, combining Sharpe, Sortino, and other metrics used by quantitative funds and institutional investors.

ADMA vs. CHOLAFIN.NS - Risk-Adjusted Trends Comparison

This table presents a comparison of risk-adjusted performance metrics for ADMA Biologics, Inc. (ADMA) and Cholamandalam Investment and Finance Company Limited (CHOLAFIN.NS). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.

Values are calculated on a 1-year rolling basis and updated daily. Risk-adjusted metrics are more stable over longer periods — use the period switch above to explore them.

	ADMA	CHOLAFIN.NS	Difference
Sharpe ratio: Return per unit of total volatility	-1.14	-0.32	-0.82
Sortino ratio: Return per unit of downside risk	-1.82	-0.26	-1.56
Omega ratio: Gain probability vs. loss probability	0.76	0.97	-0.21
Calmar ratio: Return relative to maximum drawdown	-0.98	-0.38	-0.59
Martin ratio: Return relative to average drawdown	-1.95	-0.91	-1.04

ADMA vs. CHOLAFIN.NS - Sharpe Ratio Comparison

The current ADMA Sharpe Ratio is -1.14, which is lower than the CHOLAFIN.NS Sharpe Ratio of -0.32. The chart below compares the historical Sharpe Ratios of ADMA and CHOLAFIN.NS, calculated using daily returns over the previous 12 months. A higher Sharpe Ratio indicates better risk-adjusted performance relative to the risk-free rate.

Drawdowns

ADMA vs. CHOLAFIN.NS - Drawdown Comparison

The maximum ADMA drawdown since its inception was -91.28%, which is greater than CHOLAFIN.NS's maximum drawdown of -83.98%. Use the drawdown chart below to compare losses from any high point for ADMA and CHOLAFIN.NS.

Drawdown Indicators

	ADMA	CHOLAFIN.NS	Difference
Max Drawdown Largest peak-to-trough decline	-91.28%	-83.98%	-7.30%
Max Drawdown (1Y) Largest decline over 1 year	-63.48%	-28.22%	-35.26%
Max Drawdown (3Y) Largest decline over 3 years	-68.99%	-30.67%	-38.32%
Max Drawdown (5Y) Largest decline over 5 years	-68.99%	-30.67%	-38.32%
Max Drawdown (10Y) Largest decline over 10 years	-86.11%	-66.33%	-19.78%
Current Drawdown Current decline from peak	-66.50%	-17.66%	-48.84%
Average Drawdown Average peak-to-trough decline	-53.05%	-16.47%	-36.58%
Ulcer Index Depth and duration of drawdowns from previous peaks	33.85%	11.81%	+22.04%

Volatility

ADMA vs. CHOLAFIN.NS - Volatility Comparison

The current volatility for ADMA Biologics, Inc. (ADMA) is 9.74%, while Cholamandalam Investment and Finance Company Limited (CHOLAFIN.NS) has a volatility of 12.20%. This indicates that ADMA experiences smaller price fluctuations and is considered to be less risky than CHOLAFIN.NS based on this measure. The chart below showcases a comparison of their rolling one-month volatility.

Volatility by Period

	ADMA	CHOLAFIN.NS	Difference
Volatility (1M) Calculated over the trailing 1-month period	9.74%	12.20%	-2.46%
Volatility (6M) Calculated over the trailing 6-month period	45.54%	27.89%	+17.65%
Volatility (1Y) Calculated over the trailing 1-year period	54.60%	34.20%	+20.40%
Volatility (5Y) Calculated over the trailing 5-year period, annualized	59.47%	34.85%	+24.62%
Volatility (10Y) Calculated over the trailing 10-year period, annualized	69.03%	41.98%	+27.05%

Dividends

ADMA vs. CHOLAFIN.NS - Dividend Comparison

ADMA has not paid dividends to shareholders, while CHOLAFIN.NS's dividend yield for the trailing twelve months is around 0.13%.

Position	TTM	2025	2024	2023	2022	2021	2020	2019	2018	2017	2016	2015
ADMA ADMA Biologics, Inc.	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%
CHOLAFIN.NS Cholamandalam Investment and Finance Company Limited	0.13%	0.12%	0.17%	0.16%	0.28%	0.38%	0.18%	8.35%	12.90%	10.58%	11.88%	13.63%

Financials

Frequently Asked Questions

Can I hold both ADMA and CHOLAFIN.NS in my portfolio?

ADMA and CHOLAFIN.NS have a correlation of -0.07, meaning they provide meaningful diversification benefit when combined. Depending on your allocation goals, holding both could reduce overall portfolio risk.